Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
Multicenter double-blind placebo-controlled parallel-group randomized clinical trial of
efficacy and safety of Raphamin in the treatment of coronavirus disease 2019 in outpatients.